Vancocin Italia Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VANCOCIN ITALIA, and what generic alternatives to VANCOCIN ITALIA drugs are available?
VANCOCIN ITALIA has one approved drug.
There are four US patents protecting VANCOCIN ITALIA drugs.
There are fifty-two patent family members on VANCOCIN ITALIA drugs in twenty countries and eleven supplementary protection certificates in ten countries.
Summary for Vancocin Italia
| International Patents: | 52 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Vancocin Italia
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vancocin Italia | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | 8,530,668 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Vancocin Italia | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | 9,427,402 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Vancocin Italia | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | 8,889,722 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Vancocin Italia | MULPLETA | lusutrombopag | TABLET;ORAL | 210923-001 | Jul 31, 2018 | RX | Yes | Yes | 7,601,746 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Vancocin Italia Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2010107169 | ⤷ Try a Trial |
| Australia | 2008283357 | ⤷ Try a Trial |
| Poland | 2184279 | ⤷ Try a Trial |
| Brazil | PI0814891 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Vancocin Italia Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2184279 | 2019/039 | Ireland | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE THEREOF.; REGISTRATION NO/DATE: EU/1/18/1348 20190218 |
| 2184279 | 1990035-6 | Sweden | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG; REG. NO/DATE: EU/1/18/1348 20190220 |
| 2184279 | CA 2019 00038 | Denmark | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG OG FARMACEUTISK ACCEPTABLE SALTE ELLER SOLVATER DERAF; REG. NO/DATE: EU/1/18/1348 20190220 |
| 2184279 | 19C1043 | France | ⤷ Try a Trial | PRODUCT NAME: LUSUTROMBOPAG, UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI OU UN SOLVATE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/18/1348 20190220 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
